Top Ten Suppliers of Synthetic Biology Technology

About This Presentation
Title:

Top Ten Suppliers of Synthetic Biology Technology

Description:

Bharat Book Presents" Top Ten Suppliers of Synthetic Biology Technology" Recent advances allowing for the better understanding of the ways in which living DNA creates the materials of life have opened remarkable new possibilities in materials science and chemical engineering. According to physicist Freeman Dyson, “The ability to design and create new forms of life marks a turning point in the history of our species and our planet.” – PowerPoint PPT presentation

Number of Views:96

less

Transcript and Presenter's Notes

Title: Top Ten Suppliers of Synthetic Biology Technology


1
Top Ten Suppliers of Synthetic Biology Technology
  • Bharat Book Bureau

2
Summary
  • REPORT HIGHLIGHTSThis report provides
  • Identification of the top 10 companies in the
    market for synthetic biology technology, and the
    rationale behind these selections.
  • Factors taken into account, including technical
    innovation, market leadership, and commitment to
    this market via investment in products.

3
Continue
  • REPORT SCOPE
  • Recent advances allowing for the better
    understanding of the ways in which living DNA
    creates the materials of life have opened
    remarkable new possibilities in materials science
    and chemical engineering. According to physicist
    Freeman Dyson, The ability to design and create
    new forms of life marks a turning point in the
    history of our species and our planet.These
    advances also mark an economic turning point,
    creating a market vision of synthetic life forms
    and life processes tailored to produce specific
    substances. The desired yield of such substances
    as biofuels can be measured in millions of tons,
    whereas pharmaceuticals can be measured in grams
    or milligrams.The door that is opening is
    likely to affect important markets for decades.
    Intense research and development continues to be
    both privately and publically funded, but the
    work has emphatically moved out of the laboratory
    and into the marketplace. Major corporations are
    putting new intellectual properties to work in
    new factories in the U.S. and abroad.

4
Continue
  • The players on this new field include new
    companies that come directly out of university
    research riding large holdings of intellectual
    property and established multinational giants
    that have the networks necessary to distribute
    and market the new materials. Between these two
    ends of the spectrum, companies are emerging that
    can intermediately supply the substances and
    services that bridge the gaps. The result is
    intricate patterns of interconnection between
    layers of the new supply chains. Acquisitions up
    and down these supply chains are frequent, as
    capital is freely available due to the obvious
    potential.This document examines 10 of the top
    companies in the field and discusses their
    positions in these complex patterns of supply and
    demand, as well as their investments and
    alliances. The chosen companies have effectively
    positioned themselves to connect the ends of the
    chain from the specialized tools and materials
    end or acquired the ability to make the most
    effective use of these tools and materials. 

5
Continue
  • BCC Research selected 10 companies that
    deserve recognition as leaders in the industry.
    Some are large established multinationals that
    have embraced the new technology. Others are
    startup pioneers that grow directly out of the
    research and development process. They areLife
    TechnologiesDNA2.0OrigeneSynthetic
    GenomicsDuPontPfizerNovozymesAmrys
    BiotechnologiesScarab GenomicsBritish
    PetroleumAny top 10 list has subjective
    elements, and thus five other companies are
    profiled in less detail.

6
Continue
  • STUDY GOALS AND OBJECTIVESThis document is
    a specialty report related to BCC Research report
    BIO066B by John Bergin. The goal of this document
    is to provide a more in-depth look at the
    top-tier synthetic biology companies, as well as
    some of the second-tier companies that are sure
    to play important roles in the years to come.
    More specifically, the objectives include
    identifying companies that are considered the
    leaders in their fields, as well as the
    technological means these companies are using to
    exploit their markets and dominate their fields. 

7
Continue
  • Synthetic biology markets reviewed in this report
    include
  • Markets by end-use segment, such as research and
    development (RD), diagnostics/pharmaceuticals,
    energy, chemicals, and agriculture.
  • Markets by product type, including enabling
    products, biologic components, integrated
    systems, and enabled products. 
  • Other major factors used to determine top
    companies in the field include
  • Alliances, mergers, and acquisition strategies.
  • Financing.
  • Intellectual property (i.e., patent) portfolios.

8
Continue
  • INTENDED AUDIENCEThe study compiles existing
    and future synthetic biology products and
    technologies that will be commercially important
    in the main end -user segments of life science
    research, pharmaceuticals, diagnostics, energy,
    chemicals, and agriculture.This report will be
    of particular interest to pharmaceutical,
    chemical, enzyme, energy, agricultural,
    biotechnology and nanobiotechnology companies, as
    well as suppliers of genomics tools, DNA
    synthesis and DNA-sequencing products. It will
    also help professionals within governments and
    regulatory agencies to understand the scope and
    pace of synthetic biology technologies as they
    reach the market. 

9
Continue
  • SCOPEThis report focuses on 10 selected
    synthetic biology companies and the key areas in
    the field driving the industry growth that allows
    these companies to succeed. Key market segments
    include synthetic genes, chassis organisms,
    biofuels, specialty chemicals and
    pharmaceuticals. Another key area is industry
    structure, with a focus on strategic alliances
    and acquisitions, as well as pertinent patent
    information.METHODOLOGYBased on primary and
    secondary market analysis, this report analyzes
    the top 10 companies in DNA sequencing, as well
    as several additional companies worth
    recognizing. 

10
Table of Contents
  • Chapter- 1 INTRODUCTION - Complimentary 3
    0 STUDY GOALS AND OBJECTIVESINTENDED
    AUDIENCESCOPEMETHODOLOGYRELATED BCC
    REPORTSBCC ONLINE SERVICESDISCLAIMERChapter-
    2 SYNTHETIC BIOLOGY OVERVIEW 4
    150 HISTORYTECHNOLOGYChapter- 3 MARKETS 9
    638 MARKET OVERVIEWSYNTHETIC BIOLOGY MARKETS
    BY END USER INDUSTRYMARKET PLAYERSMARKET
    SEGMENTSACQUISITIONS

11
For More Information You Can Visit-
  • http//www.bharatbook.com/biotechnology-marke
    t-research-reports/top-ten-suppliers-of-synthetic-
    biology-technology.html
  • Or visit us at
  • Bharat Book
    Bureau
  • Phone
    91 22 27810772, 27810773
  • Toll Free
    No for USA/Canada 1-866-279-8368
  • E-mail
    info_at_bharatbook.com
  • Website
    www.bharatbook.com
  • Twitter
    https//twitter.com/BharatBook
  • Blog
    http//www.bharatbook.com/market-reports-blog/
Write a Comment
User Comments (0)